drugset / Trial / NCT02619526

Comparative Effects of Nebivolol and Carvedilol on Diastolic Function in the Elderly Heart Failure Patients

NCT02619526

RandomizedParallel-groupOpen-labelTreatment

Summary

Heart failure (HF) is a common and disabling condition in the elderly. Randomized clinical trials and meta-analyses have clearly demonstrated that long-term use of β blockers improves the outcomes of patients with HF. However, limited data have been available on the treatment of HF with preserved ejection fraction (EF) in the elderly. No study has specifically compared the relative effectiveness of carvedilol and nebivolol in treating HF in old age patients with preserved EF.

Timeline

Start
2016-12
Primary completion
2018-07
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carvedilol Other / unclassified 25 mg
Subject Nebivolol Other / unclassified 10 mg

Indications